Related Experiment Video
Updated: Jul 4, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Compromised end-of-life syndrome in cancer patients: A clinical validation study
Antônia Rios Almeida1, Rosimere Ferreira Santana2, Marcos Venicios de Oliveira Lopes3
1Department of Neurosurgery and Thoracic Surgery, José Alencar Gomes da Silva National Cancer Institute, Rio de Janeiro, Brazil.
Purpose:
To identify the prevalence of the nursing diagnosis of compromised end-of-life syndrome in patients in end-of-life care.
Methods:
This is a clinical validation based on a cross-sectional epidemiological clinical study conducted at the National Cancer Institute in Rio de Janeiro, Brazil. The defining characteristics of a syndrome diagnosis were identified, defined as a "subset of nursing diagnoses," using sensitivity and specificity measures through the application of latent class statistical methods.
Findings:
The statistical results revealed seven nursing diagnoses characterizing the syndrome: imbalanced nutrition: less than body requirements, nausea, anxiety, ineffective breathing pattern, disturbed sleep pattern, ineffective thermoregulation, and fatigue. Compromised end-of-life syndrome was present in 76% of the sample.
Conclusion:
The study demonstrated the presence of compromised end-of-life syndrome in most end-of-life patients from the sample.
Implications For Nursing Practice:
Recognizing the presence of the syndrome diagnosis enables nurses to have efficient and effective clinical reasoning for implementing the nursing process in palliative care. CAAE Number: 85415618.0.3001.5274.
Related Concept Videos
Cancer Survival Analysis
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Ethical Dilemmas II

